Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor

NCT03688022 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tanabe Pharma America, Inc.